[1]
K. Guo, “Advantages and Disadvantages of Car-T Therapy in the Clinical Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)”, HSET, vol. 36, pp. 283–288, Mar. 2023, doi: 10.54097/hset.v36i.5685.